The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 474-482 , February 2010

Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injury

  • Ashish K. Sharma, MBBS

      Affiliations

    • Department of Surgery, University of Virginia Health System, Charlottesville, Va
    • ,
  • Victor E. Laubach, PhD

      Affiliations

    • Department of Surgery, University of Virginia Health System, Charlottesville, Va
    • Corresponding Author InformationAddress for reprints: Victor E. Laubach, PhD, University of Virginia Health System Department of Surgery, PO Box 801359, Charlottesville, VA 22908.
    • ,
  • Susan I. Ramos

      Affiliations

    • Department of Medicine, University of Virginia Health System, Charlottesville, Va
    • ,
  • Yunge Zhao, MD, PhD

      Affiliations

    • Department of Surgery, University of Virginia Health System, Charlottesville, Va
    • ,
  • George Stukenborg, PhD

      Affiliations

    • Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Va
    • ,
  • Joel Linden, PhD

      Affiliations

    • Department of Medicine, University of Virginia Health System, Charlottesville, Va
    • ,
  • Irving L. Kron, MD

      Affiliations

    • Department of Surgery, University of Virginia Health System, Charlottesville, Va
    • ,
  • Zequan Yang, MD, PhD

      Affiliations

    • Department of Surgery, University of Virginia Health System, Charlottesville, Va

Received 3 April 2009 ,Revised 15 June 2009 ,Accepted 9 August 2009.

References 

  1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report—2006. J Heart Lung Transplant. 2006;25:880–892
  2. Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg. 2001;121:1069–1075
  3. Gazoni LM, Tribble CG, Zhao MQ, Unger EB, Farrar RA, Ellman PI, et al. Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemia–reperfusion injury. Ann Thorac Surg. 2007;84:247–253
  4. Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia–reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2006;29:L1018–L1026
  5. Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage–produced TNF-alpha during pulmonary ischemia–reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2007;293:L105–L113
  6. Geudens N, Vanaudenaerde BM, Neyrinck AP, Van De Wauwer C, Vos R, Verleden GM, et al. The importance of lymphocytes in lung ischemia–reperfusion injury. Transplant Proc. 2007;39:2659–2662
  7. de Perrot M, Young K, Imai Y, Liu M, Waddell TK, Fischer S, et al. Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J Immunol. 2003;171:4995–5002
  8. Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, et al. Additive protection against lung ischemia–reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg. 2008;135:156–165
  9. Harada N, Okajima K, Murakami K, Usune S, Sato C, Ohshima K, et al. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther. 2000;294:1034–1042
  10. Okusa MD, Linden J, Macdonald T, Huang L. Selective A2A adenosine receptor activation reduces ischemia–reperfusion injury in rat kidney. Am J Physiol. 1999;277:F404–F412
  11. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006;114:2056–2064
  12. Dobson JG, Fenton RA. Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res. 1997;34:337–347
  13. Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol. 2001;132:1017–1026
  14. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, et al. A2A-adenosine receptor reserve for coronary vasodilation. Circulation. 1998;98:711–718
  15. Sharma AK, Linden J, Kron IL, Laubach VE. Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation. Respir Res. 2009;10:58
  16. Yang Z, Sharma AK, Linden J, Kron IL, Laubach VE. CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injury. J Thorac Cardiovasc Surg. 2009;137:695–702
  17. Reutershan J, Cagnina RE, Chang D, Linden J, Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol. 2007;179:1254–1263
  18. Lappas CM, Rieger JM, Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol. 2005;174:1073–1080
  19. Ohta A, Sitkovsky M. Role of G-protein–coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001;414:916–920
  20. Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MV. Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem. 1997;272:25881–25889
  21. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008;7:759–770
  22. Day YJ, Li Y, Rieger JM, Ramos SI, Okusa MD, Linden J. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia–reperfusion injury. J Immunol. 2005;174:5040–5046
  23. Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, Chen JF, et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow–derived cells. J Clin Invest. 2003;112:883–891
  24. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467–476
  25. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol. 2003;170:2106–2112

 Disclosures: Drs Linden and Kron were shareholders in Adenosine Therapeutics, LLC, the corporation that provided ATL313, during the time of this study.

 This study was funded by NIH/NHLBI grants RO1 HL077301 (to V.E.L.) and PO1 HL073361 (to J.L.).

PII: S0022-5223(09)01085-X

doi: 10.1016/j.jtcvs.2009.08.033

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 2 , Pages 474-482 , February 2010

Article Tools

* Image Usage & Resolution